Advanced search
Publication Cover
Pain Management Volume 3, 2013 - Issue 6
Submit an article Journal homepage
93
Views
0
CrossRef citations to date
0
Altmetric
Management Perspective

Best Practices in the Treatment of Neuropathic Pain

Dalia H Elmofty1 Department of Anesthesia & Critical Care, University of Chicago, 5841 S Maryland Avenue, Chicago, IL60637, USACorrespondence[email protected]
,
Magdalena Anitescu1 Department of Anesthesia & Critical Care, University of Chicago, 5841 S Maryland Avenue, Chicago, IL60637, USA
&
Asokumar Buvanendran2 Department of Anesthesiology, Rush University Medical Center, 1653 W Congress Parkway, Chicago, IL60612, USA
Pages 475-483 | Published online: 07 Nov 2013

References

  • International Association for the Study of Pain. Pain terms, a current list with definitions and notes on usage. In: Classification of Chronic Pain (2nd Edition). Merskey H, Bogduk N (Eds). IASP Press, Seattle, WA, USA, 209–214 (1994).
  • O‘Connor A . Neuropathic pain. Quality-of-life impact, costs, and cost effectiveness of therapy. Pharmacoeconomics27(2) , 95–112 (2009).
  • Jensen MP , ChadroffMJ, DworkinsRH. The impact of neuropathic pain on health-related quality of life. Review and implications. Neurology68 , 1178–1182 (2007).
  • Smith B , TorranceN, BennettM, LeeAJ. Health and quality of life associated with chronic pain of predominantly neuropathic origin in the community. Clin. J. Pain23(2) , 143–149 (2007).
  • Bouhassira D , Lanteri-MinetM, AttalN, LaurentB, TouboulC. Prevalence of chronic pain with neuropathic characteristics in the general population. Pain136 , 380–387 (2008).
  • Torrance N , SmithBH, BennettMI, LeeAJ. The epidemiology of chronic pain of predominately neuropathic origin. Results from a general population survey. J. Pain7 , 281–289 (2006).
  • Dieleman JP , KerklaanJ, HuygenF, BoumaP, SturkenboomM. Incidence rates and treatment of neuropathic pain conditions in the general population. Pain137 , 681–688 (2008).
  • Moore RA , DerryS, TaylorRS, StaubeS, PhillipsCJ. The costs and consequences of adequately managed chronic non-cancer pain and chronic neuropathic pain. Pain Pract. doi:10.1111/papr.12050 (2013) (Epub ahead of print).
  • Sang CN , GracelyRH, MasMB, BennettGJ. Capsaicin-evoked mechanical allodynia and hyperalgesia cross nerve territories: evidence for a central mechanism. Anesthesiology85 , 491–496 (1996).
  • Orstavik K , WeidnerC, SchmidtR et al. Pathological C-fibers in patients with a chronic painful condition. Brain 126 , 567–578 (2003).
  • Baron R . Mechanisms of disease: neuropathic pain – a clinical prospective. Nat. Clin. Prac. Neurol.2 , 95–106 (2006).
  • Curatolo M , Arendt-NielsenL, Petersen-FelixS. Central hypersensitivity in chronic pain: mechanisms and clinical implications. Phys. Med. Rehabil. Clin. N. Am.17 , 287–302 (2006).
  • Bennet MI , AttalN, BackonjaMM et al. Using screening tools to identify neuropathic pain. Pain 127 , 199–203 (2007).
  • Cruccu G , SommerC, AnandP et al. EFNS guidelines on neuropathic pain assessment: revised 2009. Eur. J. Pain 17 , 1010–1018 (2010).
  • Rasmussen PV , SindrupSH, JensenTS, BachFW. Symptoms and signs in patients with suspected neuropathic pain. Pain10 , 461–469 (2004).
  • Treede RD , JensenTS, CampbelJN et al. Neuropathic pain; redefinition and a grading system for clinical and research purposes. Neurology 70 , 1630–1635 (2008).
  • Finnerup NB , JensenTS. Mechanisms of disease: mechanism-based classification of neuropathic pain – a critical analysis. Nat. Clin. Pract. Neurol.2(2) , 107–115 (2006).
  • Boulton A , VinikAI, ArezzoJC et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 28(4) , 956–962 (2005).
  • Oxman MN , LevinMJ. Vaccination against herpes zoster and postherpetic neuralgia. J. Infect. Dis.197(Suppl. 2) , S228–S236 (2008).
  • Bowsher D . The effects of pre-emptive treatment of post-herpetic neuralgia with amitriptyline: a randomized, double-blinded, placebo-controlled trial. J. Pain Symptom Manage.13(6) , 327–331 (1997).
  • Buvanendran A , KroinJ, Della Valle C, Kari M, Moric M, Tuman K. Perioperative oral pregablin reduces chronic pain after total knee arthroplasty: a prospective, randomized, controlled trial. Anest. Analg.110(1) , 199–207 (2009).
  • Amr Y , YousefA. Evaluation of the efficacy of the perioperative administration of venlafaxin or gabapentin on acute or chronic post-mastectomy pain. Clin. J. Pain.26(5) , 381–385 (2012).
  • Songer D . Psychotherapeutic approaches in treatment of pain. Psychiatry2(5) , 19–24 (2005).
  • Gilron I , BaileyJM, TuD, HoldenRR, WeaverDF, HouldenRL. Morphine, gabapentin, or their combination for neuropathic pain. N. Engl. J. Med.352 , 1324–1334 (2005).
  • Hanna M , O‘BrienC, WilsonMC. Prolonged-release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients. Eur. J. Pain.12 , 804–813 (2008).
  • Chaparro LE , WiffenPJ, MooreRA, GilronI. Combination pharmacotherapy for the treatment of neuropathic pain in adults. Cochrane Database Syst. Rev.7 , CD008943 (2012).
  • Saarto T , WiffenPJ. Antidepressants for neuropathic pain. Cochrane Database Syst. Rev.4 , CD005454 (2007).
  • Pancrazio JJ , KamatchiGL, RoscoeAK, LynchC. Inhibition of neuronal Na+ channels by antidepressant drugs. J. Pharmacol. Exp. Therap.284 , 208–214 (1998).
  • Moore RA , DerryS, AldingtonD, ColeP, WiffenPJ. Amitriptyline for neuropathic pain and fibromyalgia in adults. Cochrane Database Syst. Rev.12 , CD008242 (2012).
  • Lunn MPT , HughesRAC, WiffenPJ. Duloxetine for treating painful neuropathy or chronic pain. Cochrane Database Syst. Rev.11 , CD007115 (2011).
  • Finnerup NB , OttoM, JensenTS, SindrupSH. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain118 , 289–305 (2005).
  • Max MB , LynchSA, MuirJ, ShoafS, SmollerB, DubnerR. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N. Engl. J. Med.326 , 1250–1256 (1992).
  • Semenchuk MR , ShermanS, DavisB. Double-blind, randomized trial of bupropion SR for the treatment of neuropathic pain. Neurology57 , 1583–1588 (2001).
  • Dooley DJ , TaylorCP, DonevanS et al. Ca2+ channel α2-δ ligands: novel modulators of neurotransmission. Trends Pharmacol. Sci. 28 , 75–82 (2007).
  • Caraceni A , ZeccaE, BonezziC et al. Gabapentin for neuropathic cancer pain: a randomized controlled trial from the gabapentin cancer pain study group. J. Clin. Oncol. 22 , 2909–2917 (2004).
  • Freynhagen R , StrojekK, GriesingT, WahlenE, BalkenohlM. Efficacy of pregablin in neuopathic pain evaluated in a 12-week, randomized, double-blind, multicenter, placebo-controlled trial of flexible-and fixed-dose regimens. Pain115 , 254–263 (2005).
  • Moore RA , WiffenPJ, DerryS, McQuayHJ. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst. Rev.3 , CD007938 (2011).
  • Eisenberg E , McNicolED, CarrDB. Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin. Systematic review and meta-analysis of randomized controlled trials. JAMA293(24) , 3043–3052 (2005).
  • Dworkin RH , O‘ConnorAB, BackonjaM et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 132 , 237–251 (2007).
  • Moulin DE , ClarkAJ, GilronI et al. Pharmacological management of chronic neuropathic pain-consensus statement and guidelines from the Canadian Pain Society. Pain. Res. Manage. 12(1) , 13–21 (2007).
  • Attal N , CruccuG, BaronR et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur. J. Neurol. 17 , 1113–1123 (2010).
  • Cruccu G , AzizTZ, Garcia-LarreaL et al. EFNS guidelines on neurostimulation therapy for neuropathic pain. Eur. J. Neurol. 14(9) , 952–970 (2007).
  • Jamison DE , WilkinsonIM, CohenSP. Intrathecal drug delivery for neuropathic pain. US Neurology7(2) , 154–162 (2011).
  • Park CH , JungSH, HanCG. Effects of intravenous lidocaine on the neuropathic pain of failed back surgery syndrome. Korean J. Pain25(2) , 94–98 (2012).
  • Kvarnstrom A , KarstenR, QuidingH, EmanuelssonBM, GordhT. The effectiveness of intravenous ketamine and lidocaine on peripheral neuropathic pain. Acta Anaesthesiol. Scand.47 , 868–878 (2003).
  • Shealy CN , MortimerJT, ReswickJB. Electrical inhibition of pain by simulation of the dorsal columns: preliminary clinical report. Anesth. Analg.46(4) , 489–491 (1997).
  • Melzack R , WallPD. Pain mechanisms: a theory. Science150(699) , 971–979 (1965).
  • Mailis-Gagnon A , FurlanAD, SandovalJA et al. Spinal cord stimulation for chronic pain. Cochrane Database Syst. Rev. 3 , CD003783 (2004).
  • Pluijms W , SlangenR, JoostenE et al. Electrical spinal cord stimulation in painful diabetic polyneuopathy, a systematic review on treatment efficacy and safety. Eur. J. Pain. 15 , 783–788 (2011).
  • North R , KiddD, ShipleyJ, TaylorR. Spinal cord stimulation versus reoperation for failed back surgery syndrome: a cost effectiveness and cost utility analyses based on randomized control trial. Neurosurgery61(2) , 361–369 (2007).
  • Manca A , KumarK, TaylorR et al. Quality of life, resource consumption and cost of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). Eur. J. Pain 12(8) , 1047–1058 (2008).
  • Kumar K , TaylorR, JacquesL et al. The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery 63 , 762–770 (2008).
  • North R , KumarK, WallaceM. Spinal cord stimulation versus reoperation in patients with failed back surgery syndrome: an international multicenter randomized controlled trial. Neuromodulation14 , 330–336 (2011).
  • Corning JL . Spinal anesthesia and local medication of the cord. NY Med.J.42 , 483–485 (1885).
  • Gradert TL , BazeWB, SatterfieldWC, HildebrandKR, JohansenMJ, HassenbuschSJ. Safety of chronic intrathecal morphine infusion in a sheep model. Anesthesiology99 , 188–198 (2003).
  • Osenbach R . Intrathecal drug delivery in the management of pain. In: Bonica‘s Management of Pain (4th Edition). Fishman SM, Ballantyne JC, Pathmell JP, (Eds). Lippincott Williams and Wilkins, PA, USA, 1437–1458 (2010).
  • Rauck RL , WallaceMS, BurtonAW, KapuralL, NorthJM. Intrathecal ziconotide for neuropathic pain: a review. Pain9(5) , 327–337 (2009).
  • Deer TR , PragerJ, LevyR et al. Polyanalgesic consensus conference 2012: recommendations for the management of pain by intrathecal (intraspinal) drug delivery: report of an interdisciplinary expert panel. Neuromodulation 15(5) , 436–466 (2012).
  • Finnerup N , Biering-SorensenF, JohannesenIL et al. Intravenouse lidocaine relieves spinal cord injury pain: a randomized controlled trial. Anesthesiology 102 , 1023–1030 (2005).
  • Petrenko AB , YamakuraT, BabaH et al. The role of N-methyl-D-aspartate (NMDA) receptor in pain: a review. Anesth. Analg. 97 , 25–28 (2003).
  • Fanaee E , AnitescuM, PatilSK. Sustained pain relief after lidocaine infusions for chronic pain syndromes: A retrospective analysis. Presented at: American Society of Anesthesiologists Annual Meeting. Chicago, IL, USA, 16–20 October 2010.
  • Hocking G , CousinsMJ. Ketamine in chronic pain management: an evidence-based review. Anesth. Analg.97 , 1730–1740 (2003).
  • Elsewaisy O , SlonB, MonagleJ. Analgesic effect of subanesthetic intravenous ketamine in refractory neuropatic pain: a case report. Pain Med.11 , 946–950 (2010).
  • Amr YM . Multi-day low dose ketamine infusion as adjuvant to oral gabapentin in spinal cord injury related chronic pain: a prospective, randomized, double-blinded trial. Pain Physician13 , 245–249 (2010).
  • Patil SK , AnitescuM. Efficacy of outpatient ketamine infusions in refractory chronic pain syndromes: a 5 year retrospective analysis. Pain Med.13 , 263–269 (2012).
  • Straube S , DerryS, MooreRA, McQuayHJ. Cervico-thoracic or lumbar sympathectomy for neuropathic pain and complex regional pain syndrome. Cochrane Database Syst. Rev.7 , CD002918 (2010).
  • Rupani G , AnitescuM. Celiac Plexus Block, is it effective? A retrospective analysis for redefining the efficacy of neurolysis in metastatic cancer patients with severe upper abdominal pain. Presented at: American Society of Regional Anesthesia and Pain Medicine Fall Meeting. San Antonio, Texas, USA, 19–22 November 2009.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.